Cryopreservation of cell-seeded substrates and related methods

Patent metadata

Field	Value
Publication number	US-11825839-B2
Application number	US-201916557897-A
Country	US
Kind code	B2
Filing date	Aug 30, 2019
Priority date	Sep 7, 2018
Publication date	Nov 28, 2023
Grant date	Nov 28, 2023

Abstract

Disclosed herein are methods and compositions for the identification of viability enhancing cell features and substrate features as they relate to post-cryopreservation survival of substrate seeded cells. Embodiments of the present invention further involve identification of cell features to manufacture a supernatant that is useful for cell culturing and treatment of various diseases.

First claim

What is claimed is:

1. A method of cryopreserving cells on a substrate, the method comprising:
providing a biocompatible polymer substrate seeded with a monolayer of immature retinal pigment epithelium (RPE) cells, the polymer substrate providing a cell seeding surface;
identifying when i) the monolayer of immature RPE cells reaches between 90% and 99% confluence on the substrate and ii) most of the immature RPE cells are not fully pigmented; and
exposing the monolayer of RPE cells that are between 90% and 99% confluent to a controlled temperature reduction rate between about −1° C. per minute to about −30° C. per minute until a first temperature below −20° C. is reached.

2. The method of claim 1 , wherein the cell-seeded substrate reaches a temperature below that which delineates a latent heat release of the seeded cells.

3. The method of claim 2 , wherein a surface of the substrate is substantially parallel to the monolayer of the immature RPE cells seeded on the substrate, sufficient to induce nucleation and efficient temperature compensation in response to the latent heat release of the seeded cells.

4. The method of claim 1 , further comprising:
maintaining the cell-seeded substrate at the first temperature, the first temperature being between −20° C. to about −100° C. after the controlled temperature reduction rate for a first period of time to obtain uniformity of temperature; and
maintaining the cells at a storage temperature lower than the first temperature for a second period of time within 50° C. of the first temperature, thereby obtaining cryopreserved cells.

5. The method of claim 1 , further comprising:
maintaining the cell-seeded substrate at the first temperature, the first temperature being between −20° C. to about −100° C. after the controlled temperature reduction rate for a first period of time; and
conducting a second controlled temperature reduction rate to finally maintain the cells at a storage temperature below −196° C. for a second period of time, thereby obtaining cryopreserved cells.

6. The method of claim 5 , wherein the second period of time is between 24 hours and 60 months.

7. The method of claim 5 , wherein the second controlled temperature reduction rate is between about −1° C. per minute to about −30° C. per minute.

8. The method of claim 1 , wherein the monolayer of cells has a cell seeding density between 200,000 and 700,000 cells per milliliter of cell suspension, or between 100,000 and 350,000 cells per square centimeter of substrate surface.

9. The method of claim 1 , wherein over 50% of the RPE cells have a cobblestone morphology.

10. The method of claim 1 , wherein the RPE cells have no pigmentation or only partial pigmentation.

11. The method of claim 1 , wherein the monolayer of RPE cells exhibit cryopreservation viability characteristics selected from: adhered but non-polarized, partially polarized, or fully polarized RPE cells, RPE cells with or without mature cobblestone morphology, RPE cells with gene expression levels below that of mature cells or lacking specific gene expression of mature cells.

12. The method of claim 1 , wherein the substrate has one or more characteristics selected from: (i) a coefficient of thermal expansion of the substrate, (ii) a substrate elasticity parameter, (iii) a substrate thickness, (iv) surface modification, (v) shear force resistance, said characteristics helping to enhance viability of the seeded cells and functionality of the substrate during cryopreservation and thawing.

13. The method of claim 1 , wherein the biocompatible polymer substrate comprises parylene.

14. The method of claim 1 , further comprising:
determining when at least one or more apical secretions, basal secretions, or non-polar specific secretions of the immature RPE cells are at levels below that of mature RPE cells.

15. The method of claim 14 , wherein the apical secretions comprise αB crystallin, hyaluronan, matrix metallopeptidase (MMP)-9, pigment epithelium-derived factor PEDF), transforming growth factor (TGF)-β, tissue inhibitors of metalloproteinases (TIMP)-I, or mechano growth factor (MGF)-E8.

16. The method of claim 14 , wherein the basal secretions comprise cystatin C, endothelin I, fibroblast growth factor (FGF) 5 , or vascular endothelial growth factor (VEGF).

17. The method of claim 14 , wherein the non-polar specific secretions comprise brain-derived neurotrophic factor (BDNF), complement factor H (CFH), ciliary neurotrophic factor (CNTF), fibulin 3/5, fibroblast growth factor (FGF) 2, heparin binding-epidermal growth factor (HB-EGF), hepatocyte growth factor (HGF), insulin-like growth factor (IGF)-I, leukemia inhibitory factor (LIF), matrix metalloproteinase (MMP)-9, nerve growth factor (NGF), or Tropoelastin.

18. The method of claim 1 , further comprising:
determining gene expression of the immature RPE cells of at least one or more of RPE65, REX1, EIF2B2, SERF2, UBE2R2 to be below that of mature RPE cells.

19. The method of claim 1 , wherein the substrate comprises thin regions configured to allow the cells to diffuse nutrients therethrough.

20. A method of generating an implantable cell seeded substrate, the method comprising:
providing a biocompatible polymer substrate seeded with a monolayer of immature retinal pigment epithelium (RPE) cells, the polymer substrate providing a cell seeding surface;
cryopreserving cells that are between 90% and 99% confluent on the substrate by exposing the substrate seeded with cells to a controlled temperature reduction rate between about −1° C. per minute to about −30° C. per minute;
transferring the cell seeded substrate to a temperature below 4° C., thereby obtaining cryopreserved or hibernated cells;
thawing the cryopreserved cells on said substrate by warming the cell seeded substrate to a target temperature using a temperature ramp-up heating rate to obtain thawed cells seeded on the substrate, wherein the thawed cells retain viability and/or functionality post-thaw; and
culturing the seeded cells in a first medium comprising a basal medium supplemented with a combination of consisting of at least one or more of bovine serum albumin (BSA), activin A, hepatocyte growth factor (FGF), insulin-like growth factor (IGF) 1 , Dickkopf-related protein 1 (DKK1), and noggin.

Assignees

• Univ Southern California
• Univ California

Inventors

• Pennington Britney O
• Bailey Jeffrey K
• Faynus Mohamed A
• Arnold Cassidy
• Johnson Lincoln V
• Clegg Dennis O
• Humayun Mark S
• Hinton David R
• Zhu Danhong
• Mitra Debbie

Classifications

• C12N2501/15

  Transforming growth factor beta (TGF-β) · CPC title

• C12N2501/165

  Vascular endothelial growth factor [VEGF] · CPC title

• C12N2501/135

  Platelet-derived growth factor [PDGF] · CPC title

• C12N2501/235

  Leukemia inhibitory factor [LIF] · CPC title

• C12N2501/19

  Growth and differentiation factors [GDF] · CPC title